VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DMAC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DMACDiaMedica Therapeutics Inc.
$7.22$389M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDMACQuarterly Financials

DiaMedica Therapeutics Inc. (DMAC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

DiaMedica Therapeutics Inc. (DMAC) quarterly income statement — complete revenue, gross profit & net income history

DMAC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses10.48M9.21M9.03M8.01M8.14M8.42M6.88M5.64M5.74M5.85M5.16M4.74M5.52M3.97M3.13M3.36M3.54M3.25M3.42M3.37M
OpEx % of Revenue--------------------
Selling, General & Admin2.5M2.51M2.6M2.19M2.49M1.95M1.9M1.71M2.06M2.17M1.89M2.2M1.9M1.7M1.49M1.41M1.56M1.38M1.08M1.21M
SG&A % of Revenue--------------------
Research & Development7.99M6.7M6.44M5.82M5.66M6.47M4.98M3.93M3.68M3.68M3.27M2.54M3.62M2.27M1.64M1.96M1.97M1.87M2.33M2.16M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-10.48M-9.21M-9.03M-8.01M-8.14M-8.42M-6.88M-5.64M-5.74M-5.85M-5.16M-4.74M-5.52M-3.97M-3.13M-3.36M-3.54M-3.25M-3.42M-3.37M
Operating Margin %--------------------
Operating Income Growth %-28.71%-9.43%-31.24%-42.02%-41.86%-43.96%-33.47%-18.92%-3.98%-47.19%-64.87%-40.93%-56.14%-22.4%8.43%0.03%2.29%23.95%-2.92%-24.26%
EBITDA-10.47M-9.2M-9.02M-8M-8.13M-8.41M-6.87M-5.63M-5.73M-5.84M-5.15M-4.73M-5.51M-3.97M-3.12M-3.36M-3.53M-3.24M-3.41M-3.36M
EBITDA Margin %--------------------
EBITDA Growth %-28.75%-9.44%-31.17%-42.22%-41.86%-43.97%-33.48%-18.88%-3.97%-47.21%-64.98%-40.98%-56.2%-22.44%8.48%0.03%2.3%24%-2.9%-24.27%
D&A (Non-Cash Add-back)11K11K18K3K11K11K10K10K8K8K8K7K7K6K7K6K6K6K6K6K
EBIT-10.48M-9.21M-9.03M-8.01M-8.14M-7.89M-6.88M-5.64M-5.74M-5.14M-5.16M-4.74M-5.52M-3.97M-3.05M-3.35M-3.54M-3.25M-3.42M-3.37M
Net Interest Income0000000000000194K0035K000
Interest Income0000000000000353K0035K000
Interest Expense0000000000000159K000000
Other Income/Expense447K483K419K314K443K528K616K526K597K709K693K271K256K229K76K13K35K7K-27K98K
Pretax Income-10.04M-8.73M-8.61M-7.69M-7.7M-7.89M-6.27M-5.11M-5.14M-5.14M-4.46M-4.47M-5.26M-3.74M-3.05M-3.35M-3.5M-3.24M-3.44M-3.27M
Pretax Margin %--------------------
Income Tax-7K10K6K6K6K9K7K7K7K22K7K7K7K7K7K7K7K7K7K7K
Effective Tax Rate %0.07%-0.11%-0.07%-0.08%-0.08%-0.11%-0.11%-0.14%-0.14%-0.43%-0.16%-0.16%-0.13%-0.19%-0.23%-0.21%-0.2%-0.22%-0.2%-0.21%
Net Income-10.04M-8.74M-8.62M-7.7M-7.71M-7.9M-6.27M-5.12M-5.15M-5.16M-4.47M-4.48M-5.27M-3.75M-3.06M-3.36M-3.51M-3.25M-3.45M-3.27M
Net Margin %--------------------
Net Income Growth %-30.3%-10.63%-37.39%-50.4%-49.62%-53.07%-40.33%-14.34%2.3%-37.59%-46.16%-33.32%-50.29%-15.56%11.33%-2.57%3.15%22.71%-8.05%-32.34%
Net Income (Continuing)-10.03M-8.74M-8.62M-7.7M-7.71M-7.9M-6.27M-5.12M-5.15M-5.16M-4.47M-4.48M-5.27M-3.75M-3.06M-3.36M-3.51M-3.25M-3.45M-3.27M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.19-0.17-0.17-0.18-0.18-0.18-0.15-0.13-0.14-0.14-0.12-0.16-0.20-0.14-0.12-0.13-0.13-0.17-0.18-0.17
EPS Growth %-5.56%5.56%-13.33%-38.46%-28.57%-28.57%-25%18.75%30%0%0%-23.08%-53.85%17.65%33.33%23.53%31.58%32%5.26%0%
EPS (Basic)-0.19-0.17-0.17-0.18-0.18-0.18-0.15-0.13-0.14-0.14-0.12-0.16-0.20-0.14-0.12-0.13-0.13-0.17-0.18-0.17
Diluted Shares Outstanding53.79M46.98M49.63M42.96M42.84M42.82M42.75M38.07M37.96M37.96M37.95M27.31M26.45M26.44M26.44M26.44M26.44M19.04M19.04M18.79M
Basic Shares Outstanding53.79M46.98M49.63M42.96M42.84M42.82M42.75M38.07M37.96M37.96M37.95M27.31M26.45M26.44M26.44M26.44M26.44M19.04M19.04M18.79M
Dividend Payout Ratio--------------------